检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]天津市医科大学总医院肿瘤科,天津300052
出 处:《武警医学院学报》2009年第11期950-952,共3页Acta Academiae Medicinae CPAPF
摘 要:【目的】研究适合老年非小细胞肺癌患者的含铂化疗方案。【方法】选择37例ⅢB-Ⅳ期老年非小细胞肺癌患者,分为TC治疗组(Paclitaxel,紫杉醇联合Carboplatin,卡铂)及GP治疗组(Gemcitabine,吉西他滨联合Cisplatin,顺铂),观察其近期疗效和毒副反应。【结果】TC治疗组和GP治疗组有效率分别为23.5%(4/17)和25%(5/20),P=1,差异无统计学意义。GP治疗组Ⅲ-Ⅳ度恶心呕吐发生率高于TC治疗组的发生率,P=0.000,有统计学意义。两组Ⅲ-Ⅳ度白细胞减少以及肝功能变化无差异,P>0.05。【结论】初步研究结果提示,两者均是治疗晚期非小细胞肺癌的有效方案,TC方案依从性好,适用于老年患者。[Objective] To study which cisplatin - based regiment is suitable for older people with non - small cell lung cancer. [Methods] 37 cases of non - small cell lung cancer patients were treated with TC (PTX + CBP) or GP (GEM + DDP) for evaluating the clinical efficacy and toxicity. [Results] The response rate (RR) in Group TC and Group GP were 23.5%(4/17) and 25% (5/20), respectively, P = 1. The main toxicity was hematological toxicity, nausea and vomiting. The incidences of Ⅲ-Ⅳ Grade of nausea and vomiting in Group GP were significantly higher than those in Group TC, P = 0.000. [Conclusions] The efficiency is similar in two groups in the treatment of NSCLC, but Group TC has good compliance and it was referred to older people with non-small cell lung cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229